These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8948505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of Ibudilast on lower limb circulation of diabetic patients with minimally impaired baseline flow: a study using color Doppler ultrasonography and laser Doppler flowmetry.
    Sone H, Okuda Y, Asakura Y, Asano M, Mizutani M, Bannai C, Yamashita K.
    Angiology; 1995 Aug; 46(8):699-703. PubMed ID: 7639416
    [Abstract] [Full Text] [Related]

  • 3. Effect of beraprost sodium on peripheral circulatory disturbances induced by various stimuli.
    Nishio S, Yamada N, Endoh T, Isogaya M, Fukatsu Y, Nishimura S, Kanai N, Umetsu T.
    Arzneimittelforschung; 1989 Oct; 39(10):1229-34. PubMed ID: 2514691
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of microangiopathy of the skin in patients with non-insulin-dependent diabetes mellitus by laser Doppler flowmetry; microvasodilatory responses to beraprost sodium.
    Aso Y, Inukai T, Takemura Y.
    Diabetes Res Clin Pract; 1997 Apr; 36(1):19-26. PubMed ID: 9187411
    [Abstract] [Full Text] [Related]

  • 5. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T, Murai T, Kanai T, Ogaki Y, Sanai K, Kanda H, Sato S, Kajikawa N, Umetsu T, Matsuura H.
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [Abstract] [Full Text] [Related]

  • 6. Acute effects of thromboxane dual blocker (KDI-792) on different portions of lower limb blood flow--a study using Doppler ultrasonography and laser Doppler flowmetry in type 2 diabetic patients.
    Sone H, Okuda Y, Tsurushima Y, Asano M, Suzuki S, Kawakami Y, Yamashita K.
    Prostaglandins; 1997 Jun; 53(6):395-409. PubMed ID: 9261860
    [Abstract] [Full Text] [Related]

  • 7. [Cardiovascular effects of beraprost sodium (TRK-100), a prostacyclin analogue in the dog].
    Nishio S, Matsuura H, Hattori M, Endoh T, Yamada N, Hirano T, Murai T, Miyao Y, Kanai T, Umetsu T.
    Nihon Yakurigaku Zasshi; 1989 Dec; 94(6):351-61. PubMed ID: 2514128
    [Abstract] [Full Text] [Related]

  • 8. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
    Murata T, Sakaya S, Hoshino T, Umetsu T, Hirano T, Nishio S.
    Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of beraprost Na, a stable prostacyclin analog, on animal models of stroke.
    Hirano T, Yamori Y, Kanai N, Umetsu T, Nishio S.
    Mol Chem Neuropathol; 1992 Aug; 17(1):91-102. PubMed ID: 1388452
    [Abstract] [Full Text] [Related]

  • 11. Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in rats.
    Battal MN, Hata Y, Matsuka K, Ito O, Matsuda H, Yoshida Y, Kawazoe T, Nagao M.
    Burns; 1997 May; 23(3):232-7. PubMed ID: 9232284
    [Abstract] [Full Text] [Related]

  • 12. Effect of beraprost sodium (Procylin), a stable prostaglandin I2 analogue, on a dorsal skin flap model in rats.
    Alexandrou K, Hata Y, Matsuka K, Matsuda H.
    Scand J Plast Reconstr Surg Hand Surg; 1996 Mar; 30(1):17-22. PubMed ID: 8711437
    [Abstract] [Full Text] [Related]

  • 13. Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats.
    Umetsu T, Murata T, Nishio S.
    Arzneimittelforschung; 1989 Jan; 39(1):68-73. PubMed ID: 2541730
    [Abstract] [Full Text] [Related]

  • 14. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
    Kato H, Takashima T, Kishikawa H, Emura S, Ohmori K.
    Int J Clin Pharmacol Res; 1996 Jan; 16(4-5):99-102. PubMed ID: 9172007
    [Abstract] [Full Text] [Related]

  • 15. Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats.
    Battal MN, Hata Y, Matsuka K, Ito O, Matsuda H, Yoshida Y, Kawazoe T.
    Burns; 1996 Nov; 22(7):531-8. PubMed ID: 8909753
    [Abstract] [Full Text] [Related]

  • 16. Effects of the prostaglandin I2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitus.
    Goya K, Otsuki M, Xu X, Kasayama S.
    Metabolism; 2003 Feb; 52(2):192-8. PubMed ID: 12601631
    [Abstract] [Full Text] [Related]

  • 17. Effect of beraprost sodium on response to tests of autonomic control of heart rate in patients with diabetes mellitus.
    Noda K, Umeda F, Nawata H.
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):119-24. PubMed ID: 8792111
    [Abstract] [Full Text] [Related]

  • 18. Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.
    Belch JJ, McLaren M, Lau CS, Mackay IR, Bancroft A, McEwen J, Thompson JM.
    Br J Clin Pharmacol; 1993 Jun; 35(6):643-7. PubMed ID: 8329292
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M, Goya K, Kasayama S.
    Vasc Health Risk Manag; 2005 Jun; 1(3):209-15. PubMed ID: 17319106
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of beraprost sodium, a stable prostacyclin analogue, in diabetic cardiomyopathy.
    Ueno Y, Koike H, Nishio S.
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):603-7. PubMed ID: 8569222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.